Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth

Rationale: The expression of the chemokine (C-X-C motif) ligand 1 (CXCL1), an inflammatory protein, has been reported to be up-regulated in many human cancers. The mechanisms through which aberrant cellular CXCL1 levels promote specific steps in tumor growth and progression are unknown. Methods: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyake, Makito, Furuya, Hideki, Onishi, Sayuri, Hokutan, Kanani, Anai, Satoshi, Chan, Owen, Shi, Sixiang, Fujimoto, Kiyohide, Goodison, Steve, Cai, Weibo, Rosser, Charles J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376461/
https://www.ncbi.nlm.nih.gov/pubmed/30809313
http://dx.doi.org/10.7150/thno.29553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376461/
https://www.ncbi.nlm.nih.gov/pubmed/30809313
http://dx.doi.org/10.7150/thno.29553

Ejemplares similares